A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period.
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2015
At a glance
- Drugs Clevudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 17 Dec 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Jul 2012 Planned end date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 21 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.